Methamphetamine Addiction Treatment | Detox & Rehab in Tennessee
Methamphetamine addiction can disrupt nearly every part of a person’s life. This powerful stimulant can produce intense cravings, repeated binge-and-crash cycles, prolonged sleep disruption, changes in mood and behavior, and continued use even when someone recognizes the physical, psychological, financial, or relationship consequences.
The physical and psychological effects of long-term methamphetamine use can also be significant, affecting cardiovascular health, nutrition, dental health, sleep, cognition, mood, and mental health. Recovery is possible, but treatment often needs to address more than simply stopping methamphetamine use.
Brooks Healing Center provides methamphetamine addiction treatment in Tennessee for adults struggling with meth, crystal meth, stimulant use disorder, polysubstance use, and appropriate co-occurring mental health concerns. Located in Normandy between Nashville and Chattanooga, Brooks provides medical detox and stabilization, residential addiction treatment, evidence-based therapy, and continued treatment through our Partial Hospitalization Program (PHP) and sober living.
Table of Contents
Key Points About Methamphetamine Addiction Treatment
- Methamphetamine is a powerful central nervous system stimulant. Repeated use can produce tolerance, cravings, withdrawal, stimulant use disorder, and significant physical and mental health effects.
- Methamphetamine addiction is clinically treated as a stimulant use disorder. People may also hear the terms methamphetamine use disorder or meth addiction used to describe the same general pattern.
- Meth withdrawal is different from alcohol or benzodiazepine withdrawal. It is generally not inherently life-threatening, but severe depression, suicidal thoughts, psychosis, dehydration, sleep disruption, and other medical or psychiatric problems can require close monitoring.
- There is currently no FDA-approved medication specifically for methamphetamine use disorder. Certain medications may be considered off-label for selected patients, while behavioral treatment remains central.
- Contingency management has the strongest evidence among behavioral treatments for stimulant use disorder. Cognitive Behavioral Therapy, motivational approaches, community reinforcement, relapse-prevention work, and other therapies can also support recovery.
- Methamphetamine and opioids increasingly overlap in the illicit drug supply. Fentanyl exposure may occur intentionally or unintentionally, so treatment should assess the person’s entire substance-use pattern rather than assuming meth is the only substance involved.
- How Brooks helps: Brooks provides stimulant withdrawal stabilization, residential addiction treatment, individualized therapy, dual-diagnosis support when appropriate, PHP, supportive housing, sober living, relapse-prevention planning, and continued recovery care.
Methamphetamine Addiction Treatment at a Glance
| Brooks Program / Treatment Approach | What It Provides | When It May Be Appropriate |
|---|---|---|
| Medical Detox & Stabilization | Clinical assessment, monitoring of stimulant withdrawal and mental status, rest, nutrition, hydration, symptom management, and stabilization. | When heavy or prolonged meth use, polysubstance use, psychiatric symptoms, severe exhaustion, medical problems, or an unsafe recovery environment make structured withdrawal management appropriate. |
| Residential Treatment | 24-hour structure with individualized therapy, recovery education, mental health support, relapse prevention, peer support, and continued stabilization. | When methamphetamine use is difficult to interrupt outside treatment or substantial structure is needed after the initial crash and withdrawal period. |
| Behavioral Treatment | Evidence-based therapy targeting cravings, triggers, coping skills, emotional regulation, motivation, relapse patterns, and the circumstances surrounding stimulant use. | Throughout treatment for methamphetamine use disorder. |
| Partial Hospitalization Program (PHP) | Intensive daytime clinical treatment with therapy, medication management when appropriate, recovery education, and increasing independence. | After residential treatment or when someone is medically stable but continues to require substantial clinical structure. |
| Sober Living | Structured, substance-free housing with accountability, peer support, routines, and greater independence. | For eligible individuals who no longer require intensive clinical care but benefit from a recovery-focused living environment. |
What Is Methamphetamine?
Methamphetamine, commonly called meth, crystal meth, crystal, ice, glass, speed, or crank, is a synthetic stimulant that increases activity in the central nervous system.
Methamphetamine can increase dopamine, norepinephrine, and other neurotransmitter activity in the brain. The resulting effects may include increased energy, alertness, confidence, wakefulness, decreased appetite, and euphoria. At the same time, methamphetamine can increase heart rate, blood pressure, respiration, and body temperature and can contribute to agitation, anxiety, paranoia, insomnia, and other serious complications.
Crystal meth usually appears as clear or whitish crystalline material resembling pieces of glass or ice. Illicit methamphetamine may also appear as powder or tablets and can be smoked, snorted, swallowed, or injected.
Methamphetamine is a Schedule II controlled substance in the United States. A pharmaceutical form, Desoxyn®, has limited legitimate medical uses, but most methamphetamine used nonmedically in the United States is illicitly manufactured. DEA Diversion Control Division
Methamphetamine Quick Reference
| Category | Information |
|---|---|
| Drug Class | Central nervous system stimulant |
| Common Names | Meth, crystal meth, crystal, ice, glass, speed, crank |
| DEA Schedule | Schedule II |
| Possible Routes of Use | Smoking, snorting, swallowing, injection |
| Clinical Disorder | Stimulant use disorder / methamphetamine use disorder |
| FDA-Approved Medication for Methamphetamine Use Disorder | None currently approved |
How Common Is Methamphetamine Use?
Methamphetamine remains widely used in the United States. According to SAMHSA’s 2025 National Survey on Drug Use and Health, approximately 2.7 million people aged 12 or older reported methamphetamine use during the previous year, representing about 0.9% of that population. SAMHSA
SAMHSA also reported that approximately 4.5 million Americans had a central nervous system stimulant use disorder in 2025, a category that includes disorders involving methamphetamine, cocaine, and prescription stimulants. SAMHSA
Methamphetamine Addiction and Stimulant Use Disorder
Meth addiction does not necessarily develop in the same way for everyone. Some people begin using meth recreationally, while others are drawn to its effects on wakefulness, energy, confidence, appetite, sexual activity, or productivity. As use becomes more frequent, tolerance and cravings can develop, and some people begin using repeatedly to maintain stimulation or avoid the exhaustion and depressed mood that follow a binge.
Clinically, problematic methamphetamine use falls within stimulant use disorder. Researchers and treatment providers also commonly use the term methamphetamine use disorder when discussing meth specifically.
Under DSM-based criteria, stimulant use disorder involves a pattern of use that causes significant impairment or distress. The severity depends on the number of qualifying symptoms present.
Signs Methamphetamine Use May Have Become a Problem
Possible signs include:
- Strong cravings for methamphetamine
- Using more meth or using for longer than intended
- Repeated unsuccessful attempts to reduce or stop
- Spending substantial time obtaining, using, or recovering from meth
- Repeated binge-and-crash cycles
- Continuing to use despite relationship or family problems
- Missing work, school, appointments, or other responsibilities
- Giving up activities because of meth use
- Using in hazardous situations
- Continuing despite physical or mental health consequences
- Needing increasing amounts to achieve similar effects
- Experiencing withdrawal or a severe crash when stopping
- Staying awake for prolonged periods
- Becoming increasingly isolated or secretive
- Neglecting nutrition, hygiene, dental care, or sleep
The presence of tolerance or withdrawal alone does not describe the entire disorder. Treatment considers the broader impact methamphetamine has on health, behavior, relationships, responsibilities, and the person’s ability to control their use.
Short- and Long-Term Effects of Methamphetamine
Methamphetamine affects multiple systems in the body. The exact effects depend on the amount used, frequency, route of administration, sleep deprivation, other substances involved, medical history, and individual response.
Short-Term Effects of Meth
Short-term effects can include:
- Increased wakefulness and energy
- Euphoria
- Decreased appetite
- Rapid heart rate
- Increased blood pressure
- Elevated body temperature
- Increased breathing
- Restlessness
- Anxiety
- Agitation
- Jaw clenching or repetitive movements
- Insomnia
- Paranoia
- Hallucinations or psychosis at higher exposures or after prolonged wakefulness
Severe stimulant toxicity can involve dangerous overheating, cardiac rhythm problems, chest pain, heart attack, stroke, seizures, severe agitation, delirium, or psychosis and requires emergency medical care. CDC
Long-Term Effects of Methamphetamine Use
Long-term or frequent methamphetamine use has been associated with:
- Cardiovascular problems
- Significant sleep disruption
- Weight loss and nutritional problems
- Anxiety and mood disturbances
- Memory and concentration problems
- Reduced executive functioning
- Dental disease
- Skin injuries related to scratching or repetitive picking
- Increased risk of infection when meth is injected
- Persistent or recurrent paranoia and psychotic symptoms in some people
- Relationship, occupational, financial, and legal consequences
Some cognitive and psychological symptoms may continue after methamphetamine use stops, although recovery can occur over time. It is more accurate to discuss the possibility of persistent effects than to assume that every cognitive change represents permanent brain damage.
What Is “Meth Mouth”?
“Meth mouth” is an informal term for severe dental problems sometimes seen with chronic methamphetamine use.
The dental damage is not caused by one single mechanism. Methamphetamine use may contribute to dry mouth, jaw clenching or grinding, prolonged periods without normal dental care, frequent intake of sugary drinks, poor nutrition, and changes in daily hygiene. Together, those factors can contribute to rapid tooth decay, gum disease, broken teeth, and dental infections.
Treatment and recovery planning may therefore include attention to dental health and other medical needs that developed during active methamphetamine use.
Methamphetamine Withdrawal
Methamphetamine withdrawal often looks different from withdrawal from alcohol, opioids, or benzodiazepines. Many people experience a crash involving exhaustion, increased sleep, depression, loss of pleasure, increased appetite, irritability, and intense cravings.
Abruptly reducing or stopping heavy stimulant use can produce withdrawal symptoms within hours to days. ASAM notes that many patients experience an initial period of significant sleepiness and irritability during the first 12 to 24 hours. ASAM/AAAP guideline
Is Meth Withdrawal Dangerous?
Uncomplicated methamphetamine withdrawal is generally not considered medically life-threatening in the same way severe alcohol or benzodiazepine withdrawal can be. That does not mean it is always safe or easy to manage alone.
The most important concerns can include:
- Severe depression
- Suicidal thoughts
- Psychosis or severe paranoia
- Agitation
- Extreme sleep deprivation before the crash
- Dehydration or nutritional problems
- Cardiovascular complications related to recent stimulant use
- Co-occurring alcohol, benzodiazepine, or opioid withdrawal
- Underlying medical or psychiatric disorders
ASAM specifically recommends monitoring for worsening psychiatric symptoms and notes that suicidality can increase as stimulant intoxication wears off and acute withdrawal begins. ASAM/AAAP guideline
Anyone experiencing suicidal thoughts, hallucinations, extreme paranoia, chest pain, seizure, severe confusion, dangerous agitation, or other rapidly worsening symptoms should receive immediate medical evaluation.
How Long Does Meth Withdrawal Last?
There is no single exact timeline for methamphetamine withdrawal.
A general pattern may look like this:
| Period After Stopping | What May Occur |
|---|---|
| First 12–24 hours | A pronounced crash may begin, with exhaustion, increased sleep, irritability, low mood, and increased appetite. |
| First 2–3 days | Fatigue, depression, sleep changes, cravings, anxiety, irritability, and concentration problems may be particularly noticeable. |
| Approximately days 4–7 | Many acute symptoms begin to decrease, although energy, mood, motivation, and sleep may remain disrupted. |
| Following 1–3 weeks | Cravings, low energy, anxiety, disrupted sleep, concentration problems, and mood symptoms may continue in some people. |
| Weeks to months in some patients | Post-acute symptoms such as depression, anxiety, insomnia, paranoia, cognitive difficulty, or cravings can persist and should be evaluated rather than assumed to follow a fixed timeline. |
Research on psychostimulant withdrawal generally finds that acute discomfort is greatest during the first several days and often decreases substantially within the first week, while some symptoms can persist longer. Clinical management of psychostimulant withdrawal
Meth Withdrawal Symptoms
Possible symptoms include:
- Extreme fatigue
- Increased sleeping or difficulty regulating sleep
- Vivid or unpleasant dreams
- Increased appetite
- Depressed or dysphoric mood
- Loss of pleasure or motivation
- Anxiety
- Irritability
- Agitation
- Poor concentration
- Slowed thinking
- Stimulant cravings
- Psychomotor slowing or restlessness
- Paranoia or other psychiatric symptoms in some people
The psychological component of meth withdrawal can be significant. Someone who has been awake for prolonged periods may initially sleep for long stretches, while depression and cravings can become more noticeable after the stimulant effects wear off.
Can You Detox From Meth at Home?
Some people stop methamphetamine without requiring inpatient medical withdrawal management, but home withdrawal is not automatically appropriate for everyone.
Professional assessment becomes particularly important when there is:
- Heavy or frequent meth use
- Prolonged wakefulness
- Previous methamphetamine psychosis
- Severe depression
- Suicidal thoughts
- Significant agitation or paranoia
- Serious heart or blood-pressure problems
- Polysubstance use
- Alcohol or benzodiazepine dependence
- Possible fentanyl or opioid exposure
- Pregnancy
- Repeated unsuccessful attempts to stop
- No safe or stable recovery environment
The initial crash can also create a false sense that the main problem is over once someone sleeps and eats. Cravings, depression, triggers, and the behaviors surrounding meth use may remain after the acute crash resolves.
Meth Detox and Stabilization at Brooks Healing Center
Medical detox at Brooks Healing Center provides a supervised setting for adults who need stabilization as methamphetamine and other substances are stopped.
With methamphetamine, detox is not simply a process of “removing meth from the body.” The immediate priorities may include allowing the body to rest, restoring sleep and nutrition, monitoring mood and mental status, addressing medical concerns, identifying other substances involved, and preparing the patient for the treatment that follows.
Are Medications Used During Meth Withdrawal?
There is no FDA-approved medication specifically for methamphetamine withdrawal. Current management is primarily supportive and symptom-based, with clinicians treating issues such as sleep disturbance, agitation, depression, anxiety, psychosis, or other medical and psychiatric needs when appropriate. Clinical management of psychostimulant withdrawal
Medication should be individualized rather than presented as a universal meth detox protocol.
What Happens During Meth Detox?
Assessment may include:
- Amount and frequency of methamphetamine use
- Route of administration
- Duration of use
- Recent binge patterns
- How long the person has been awake
- Current sleep and nutritional status
- Depression, anxiety, paranoia, or hallucinations
- Suicidal thoughts or safety concerns
- Cardiovascular symptoms
- Previous stimulant withdrawal
- Alcohol use
- Benzodiazepine use
- Opioid or fentanyl exposure
- Other stimulant use
- Current medications
- Medical conditions
- Co-occurring mental health conditions
- Previous addiction treatment
The clinical team can then monitor symptoms and determine when someone is stable enough to participate more fully in residential treatment.
Can Meth Withdrawal Symptoms Last After the Initial Crash?
Yes. Some people continue to experience cravings, low mood, anxiety, disrupted sleep, reduced motivation, concentration problems, or paranoia after the most obvious acute withdrawal symptoms have improved.
Current stimulant-treatment guidance describes these as post-acute stimulant withdrawal symptoms and notes that they can sometimes continue for weeks or months. Persistent symptoms should be evaluated individually because depression, anxiety, psychosis, sleep disorders, trauma-related symptoms, and other medical or psychiatric conditions can overlap with withdrawal. ASAM/AAAP guideline
Residential Methamphetamine Addiction Treatment
Detox and stabilization address the immediate crash and withdrawal period. They do not automatically change the patterns that made methamphetamine use difficult to stop.
After stabilization, appropriate patients can transition directly into residential addiction treatment at Brooks. Residential care provides a 24-hour structured environment where patients can begin rebuilding sleep, nutrition, emotional stability, daily routines, relationships, coping skills, and recovery support while reducing immediate access to methamphetamine.
Treatment may address:
- Stimulant cravings
- Binge-and-crash patterns
- Sleep and routine
- Emotional regulation
- Distress tolerance
- Impulsivity
- Depression and anxiety
- Trauma and grief
- Paranoia or psychotic symptoms when clinically appropriate
- Relationships and boundaries
- Sexual behaviors associated with stimulant use
- Nutrition and physical health
- Relapse-prevention planning
- Recovery support
- Planning for work, housing, and everyday responsibilities
Recovery from methamphetamine addiction often involves learning how to function without the artificial stimulation the drug previously provided. Energy, motivation, pleasure, sleep, and concentration may take time to normalize, which makes continued treatment after the initial crash especially important.
Partial Hospitalization and Continued Recovery
Residential treatment is not necessarily the end of methamphetamine treatment.
Brooks’ Partial Hospitalization Program provides intensive daytime clinical care at the Normandy campus for patients who are medically stable but continue to need substantial therapeutic structure.
PHP may include therapy, recovery education, medication management when appropriate, relapse-prevention planning, mental health support, and preparation for increasing independence.
PHP Housing in Tullahoma
Eligible patients participating in clinical PHP at the Normandy campus may use Brooks’ supportive housing in Tullahoma outside treatment hours.
The distinction is important: clinical PHP is provided in Normandy; PHP housing is located in Tullahoma.
Sober Living and Long-Term Recovery
For eligible individuals who no longer require intensive clinical treatment but continue to benefit from structure, Brooks provides sober living in Tullahoma.
Sober living can provide accountability, substance-free housing, routine, peer support, and an opportunity to practice recovery skills while work, family responsibilities, transportation, finances, and other parts of everyday life begin returning.
Therapy for Methamphetamine Use Disorder
Behavioral treatment is central to methamphetamine recovery. There are currently no FDA-approved medications specifically for methamphetamine use disorder. Contingency management has strong evidence, and therapy and recovery support remain important parts of an individualized treatment plan.
Cognitive Behavioral Therapy
Cognitive Behavioral Therapy (CBT) helps patients recognize connections between thoughts, feelings, situations, cravings, and substance use.
For methamphetamine recovery, CBT may involve identifying triggers, challenging patterns that rationalize stimulant use, developing strategies for cravings, and creating alternatives to behaviors that previously led into a binge.
SAMHSA identifies CBT as one of the behavioral approaches with evidence for treating stimulant use disorders. SAMHSA
Dialectical Behavior Therapy
Dialectical Behavior Therapy (DBT) emphasizes emotional regulation, distress tolerance, mindfulness, and interpersonal effectiveness.
These skills can be useful when methamphetamine has become a way of managing emotional pain, boredom, conflict, anxiety, rejection, impulsivity, or overwhelming stress.
Trauma-Informed Therapy
Trauma can intersect with stimulant use, although treatment should not assume trauma is responsible for every person’s addiction.
Trauma-informed therapy allows traumatic experiences and trauma-related symptoms to be addressed when relevant while maintaining safety and individualized treatment planning.
Experiential Therapy
Experiential therapy uses structured experiences to help patients work on emotions, relationships, communication, self-awareness, and coping outside a traditional talk-therapy format.
Brooks may also incorporate additional modalities based on the patient’s individual needs rather than using the same therapeutic combination for every person.
Contingency Management for Stimulant Use Disorder
Contingency management (CM) has the strongest evidence of any behavioral intervention currently studied for stimulant use disorder.
CM reinforces treatment goals through tangible incentives tied to objective behaviors such as treatment attendance or stimulant-negative drug tests. The ASAM/AAAP Clinical Practice Guideline describes contingency management as the current standard of care for stimulant use disorder and recommends combining it with other evidence-based approaches when appropriate. ASAM/AAAP guideline
Contingency management is a specific clinical intervention and should not be assumed to be available through every program or insurance plan. The treatment team can discuss which behavioral interventions are available within a patient’s current and continuing-care plan.
Are There Medications for Methamphetamine Addiction?
There is currently no FDA-approved medication specifically for methamphetamine use disorder. That remains an important distinction.
However, the absence of an FDA-approved medication does not mean medications are never relevant. Current ASAM/AAAP guidance allows appropriately trained clinicians to consider certain medications off-label for selected patients with amphetamine-type stimulant use disorder.
One example is a combination of bupropion and naltrexone, which has shown benefit in clinical research and may be considered for some patients. It is not an FDA-approved methamphetamine treatment, is not appropriate for everyone, and requires careful evaluation of other medical conditions, medications, seizure risk, and opioid exposure. ASAM/AAAP guideline
Medications may also be used to appropriately treat co-occurring depression, anxiety, psychosis, ADHD, sleep concerns, or another diagnosed condition. The goal is individualized treatment rather than prescribing a single “meth medication” to everyone.
Methamphetamine and Mental Health
Methamphetamine use can overlap with depression, anxiety, PTSD, bipolar symptoms, psychosis, sleep disorders, and other psychiatric concerns.
Sometimes a mental health problem predates stimulant use. In other cases, prolonged methamphetamine use, sleep deprivation, withdrawal, or intoxication can produce symptoms that resemble a primary psychiatric disorder.
Brooks provides dual-diagnosis treatment for appropriate co-occurring mental health conditions that can be safely managed within our addiction-treatment setting.
Methamphetamine-Induced Psychosis
Methamphetamine can cause psychotic symptoms including:
- Paranoia
- Hallucinations
- Delusional beliefs
- Severe suspiciousness
- Disorganized thinking
- Extreme agitation
- Difficulty distinguishing reality from stimulant-related perceptions
Psychosis may occur during heavy methamphetamine use, prolonged sleep deprivation, or sometimes during the period after use stops. For some people, symptoms resolve as intoxication and sleep deprivation improve; in other cases, symptoms may continue and require additional psychiatric assessment.
Brooks provides additional information on drug-induced psychosis and addiction treatment.
Severe paranoia, hallucinations, violent or dangerous behavior, inability to care for oneself, or suicidal thoughts require urgent professional evaluation.
Methamphetamine, Fentanyl, and Polysubstance Risk
Modern methamphetamine treatment also has to consider the broader illicit drug supply.
Methamphetamine and opioids may be used together intentionally, and people can also be exposed to fentanyl or other substances without realizing exactly what is present in a powder or counterfeit product. CDC defines polysubstance exposure as the use or presence of multiple drugs with or without the person’s knowledge. CDC
CDC overdose data show substantial overlap between stimulant- and opioid-involved deaths. During January 2021 through June 2024, 43.1% of overdose deaths involved both stimulants and opioids. That statistic includes multiple stimulants and should not be interpreted to mean that 43.1% of methamphetamine itself contains fentanyl; it demonstrates how frequently stimulant and opioid exposure overlap in fatal overdoses. CDC
Brooks’ fentanyl addiction treatment resource provides additional information about fentanyl exposure and overdose risk.
Does Naloxone Reverse a Meth Overdose?
Naloxone does not reverse methamphetamine toxicity, because methamphetamine is a stimulant rather than an opioid.
However, if someone who has used methamphetamine is unconscious, has very slow or stopped breathing, or may also have been exposed to fentanyl or another opioid, give naloxone if it is available and call 911.
Naloxone can reverse the opioid component of an overdose even though it will not treat methamphetamine-related overheating, heart problems, agitation, or psychosis.
Why Choose Brooks for Meth Rehab in Tennessee?
Brooks Healing Center provides a connected addiction-treatment continuum from our 36-acre campus in Normandy, Tennessee, between Nashville and Chattanooga.
Someone entering treatment for meth addiction may need a period of stabilization and rest before being able to participate fully in therapy. When clinically appropriate, that patient can continue from detox and stabilization into residential treatment rather than having to identify a separate treatment provider once the initial crash improves.
Brooks’ meth treatment continuum may include:
- Medical detox and stabilization
- Residential addiction treatment
- Individual and group therapy
- Cognitive Behavioral Therapy
- Dialectical Behavior Therapy
- Trauma-informed treatment
- Experiential therapy
- Relapse-prevention planning
- Support for appropriate co-occurring mental health concerns
- Dual-diagnosis treatment
- Medication management when clinically appropriate
- Partial Hospitalization Program
- Supportive PHP housing in Tullahoma
- Sober living
- Continuing recovery planning
Brooks is accredited by The Joint Commission and licensed by the Tennessee Department of Mental Health and Substance Abuse Services. View Brooks Healing Center’s licensure and credentials.
Does Insurance Cover Meth Addiction Treatment?
Many health insurance plans provide benefits for substance use disorder treatment, although exact coverage depends on the individual plan, network status, recommended level of care, medical necessity, deductible, coinsurance, and authorization requirements.
Brooks’ admissions team can verify your insurance benefits before admission and explain the information provided by your insurance carrier.
Insurance verification is not a guarantee of payment, but it can help patients and families understand the benefits that may be available under a particular plan.
Get Help for Methamphetamine Addiction in Tennessee
Methamphetamine addiction does not have to continue until someone develops psychosis, experiences a medical emergency, loses a relationship, or reaches someone else’s definition of “rock bottom.”
Repeated binges, severe crashes, inability to stop, cravings, prolonged wakefulness, worsening mental health, escalating consequences, or returning to meth despite wanting to quit are all reasons to consider an assessment.
Brooks Healing Center provides methamphetamine addiction treatment in Tennessee through medical stabilization, residential care, individualized therapy, dual-diagnosis support when appropriate, PHP, supportive housing, sober living, and continued recovery planning.
Call Brooks Healing Center at (931) 486-8824 to speak with admissions.
Frequently Asked Questions About Meth Addiction Treatment
Is methamphetamine addictive?
Yes. Methamphetamine has a high potential for addiction and can produce tolerance, cravings, withdrawal, and stimulant use disorder.
Repeated use can change how strongly someone responds to methamphetamine and can contribute to increasingly frequent dosing or larger amounts in an attempt to reproduce earlier effects.
Is crystal meth different from methamphetamine?
Crystal meth is an illicit form of methamphetamine that commonly appears as clear or whitish crystals resembling glass or ice.
The terms meth, methamphetamine, and crystal meth are often used interchangeably in everyday conversation, although illicit methamphetamine can appear in several forms.
How long does meth withdrawal last?
The most intense crash and acute withdrawal symptoms often occur during the first several days after stopping methamphetamine and may improve substantially over approximately the first week.
Fatigue, cravings, sleep disruption, depression, anxiety, concentration problems, or other symptoms can continue for several weeks or longer in some people. There is no exact timeline that applies to everyone.
Is meth withdrawal dangerous?
Methamphetamine withdrawal is generally not considered inherently life-threatening in the same way severe alcohol or benzodiazepine withdrawal can be.
However, severe depression, suicidal thoughts, psychosis, medical problems, cardiovascular symptoms, dehydration, polysubstance withdrawal, or inability to care safely for oneself can make professional monitoring important.
Can you detox from meth at home?
Some people can stop methamphetamine without requiring inpatient medical detox, but others need structured stabilization because of severe psychiatric symptoms, prolonged sleep deprivation, medical concerns, polysubstance use, or an unsafe recovery environment.
A professional assessment can help determine the appropriate level of care.
Does Brooks provide meth detox?
Brooks provides medical detox and stabilization at the Normandy campus for clinically appropriate adults withdrawing from methamphetamine and other substances.
Stimulant detox focuses on assessment, rest, nutrition, mental-health monitoring, symptom management, medical stabilization, and preparing the patient for ongoing treatment rather than simply “flushing meth from the system.”
What treatment works best for methamphetamine addiction?
Current ASAM/AAAP guidelines identify contingency management as the behavioral intervention with the strongest evidence for stimulant use disorder. CBT and other behavioral approaches can also be used as part of a comprehensive plan. ASAM/AAAP guideline
The strongest treatment plan depends on the patient’s substance use, mental health, medical condition, living environment, relapse pattern, treatment history, and available evidence-based services.
Is there medication for meth addiction?
There is currently no FDA-approved medication specifically for methamphetamine use disorder.
Clinicians may consider selected medications off-label in appropriate patients. ASAM/AAAP guidance, for example, allows consideration of bupropion combined with naltrexone for some patients with amphetamine-type stimulant use disorder. ASAM/AAAP guideline
What is methamphetamine psychosis?
Methamphetamine-induced psychosis can involve paranoia, hallucinations, delusions, severe suspiciousness, disorganized thinking, or agitation related to stimulant use.
Some symptoms resolve after methamphetamine use stops and sleep improves, while others may persist and require psychiatric evaluation. Brooks treats appropriate co-occurring addiction and drug-induced psychosis.
Can methamphetamine cause a heart attack or stroke?
Yes. Methamphetamine can significantly increase heart rate, blood pressure, and body temperature. Severe stimulant toxicity can contribute to heart attack, abnormal heart rhythms, stroke, hyperthermia, seizures, and other medical emergencies. CDC
Chest pain, severe headache, seizure, loss of consciousness, extreme overheating, or stroke-like symptoms require emergency medical care.
Can methamphetamine contain fentanyl?
Fentanyl or other opioids can sometimes be present alongside illicit stimulants, and methamphetamine and fentanyl may also be intentionally used together.
It should not be assumed that every methamphetamine product contains fentanyl. The broader concern is that illicit products are unregulated and polysubstance exposure can occur knowingly or unknowingly.
Does Narcan work for a meth overdose?
Naloxone, commonly known by the brand name Narcan, does not reverse methamphetamine toxicity.
If opioid exposure is possible, however, naloxone should still be given because it can reverse respiratory depression caused by fentanyl or another opioid. Call 911 during a suspected overdose.
Can Brooks treat meth addiction and mental health conditions together?
Brooks provides dual-diagnosis treatment for appropriate co-occurring mental health conditions that can be safely managed in the addiction-treatment setting.
Treatment planning may address depression, anxiety, trauma-related symptoms, stimulant-induced psychosis, sleep disruption, and other concerns alongside methamphetamine addiction when clinically appropriate.
How long does meth rehab last?
There is no single appropriate length of treatment for everyone.
Treatment duration depends on withdrawal and psychiatric stability, the severity of stimulant use disorder, progress in therapy, living environment, relapse risk, co-occurring conditions, insurance authorization, and the level of structure someone continues to need.
Does insurance cover meth rehab?
Many health insurance plans provide substance use disorder treatment benefits. Exact coverage depends on the individual policy and clinical recommendations.
Brooks can verify insurance benefits before admission.
Sources
- American Society of Addiction Medicine & American Academy of Addiction Psychiatry. (2024). The ASAM/AAAP clinical practice guideline on the management of stimulant use disorder.
- Substance Abuse and Mental Health Services Administration. (2026). Key substance use and mental health indicators in the United States: Results from the 2025 National Survey on Drug Use and Health.
- Substance Abuse and Mental Health Services Administration. (n.d.). Stimulants: Side effects, short- and long-term risks.
- Substance Abuse and Mental Health Services Administration. (2021). Chapter 3—Medical aspects of stimulant use disorders. In Treatment for stimulant use disorders (Treatment Improvement Protocol Series No. 33).
- Centers for Disease Control and Prevention. (2025, July 17). Stimulants.
- Tanz, L. J., Miller, K. D., Dinwiddie, A. T., Gladden, R. M., Asher, A., Baldwin, G., Nesbit, B., & O’Donnell, J. (2025). Drug overdose deaths involving stimulants—United States, January 2018–June 2024. Morbidity and Mortality Weekly Report, 74(32), 491–499.
- Centers for Disease Control and Prevention. (2024). Polysubstance overdose.
- Drug Enforcement Administration. (2025). Methamphetamine.
- Drug Enforcement Administration, Diversion Control Division. (2025). Methamphetamine (Trade name: Desoxyn®).
- Li, M. J., & Shoptaw, S. J. (2023). Clinical management of psychostimulant withdrawal: Review of the evidence. Addiction, 118(4), 750–762.